loader2
Login Open ICICI 3-in-1 Account
IPOLogoImag

NEPHROCARE HEALTH SERVICES IPO

CLOSED

IPO Details

10th Dec 2025
12th Dec 2025
32
₹ 14,016
₹ 438 - 460
₹ 871.05 Cr.

Issue timeline

  • 10-12 Dec 2025
  • 15-Dec-2025
  • 16-Dec-2025
  • 16-Dec-2025
  • 17-Dec-2025

Subscription Status

Shareholder -
Qualified Institutional Buyers -
Non-Institutional Investor -
Retail Individual Investor -
Employee -
Total -

About Company

Nephrocare Health Services Limited (Nephrocare), operating under the brand name NephroPlus, is a chain of dialysis centers, specialising in the delivery of comprehensive renal care services. The company was incorporated in 2009 and has its Registered and Corporate Office in Hyderabad, Telangana, India. Nephrocare's core focus is on providing high-quality, standardised dialysis treatment across its wide network of centers, which includes standalone facilities and units operated in partnership with hospitals. The service portfolio encompasses hemodialysis, peritoneal dialysis, and preventive renal care programs, aiming to improve the quality of life for patients with Chronic Kidney Disease (CKD).

Introduction

The Initial Public Offering (IPO) by Nephrocare Health Services Limited is structured as a 100% Book Built Offer, as detailed in the Red Herring Prospectus (RHP) dated December 2, 2025. The Offer is designed as a combination of a Fresh Issue of Equity Shares and an Offer for Sale (OFS). The Fresh Issue comprises of Equity Shares of face value of ₹2 each aggregating up to ₹3,534.05 million. The Offer for Sale involves up to 11,253,102 Equity Shares of face value of ₹2 each. The primary objective of the capital raised through the Fresh Issue is directed towards funding the establishment of new dialysis centers. Additionally, a portion of the proceeds is allocated for repayment or pre-payment of certain borrowings and general corporate purposes.

Business Model

The company improves patient accessibility through a diverse clinic network, including in-hospital captive clinics, standalone centers, and government-backed PPPs, serving patients across private hospitals and public facilities. This flexible model enables rapid scaling, proximity to care, and expansion into tier II and tier III cities. They have collaborated with leading hospital chains such as Max Super Speciality, Fortis Escorts, Care Hospitals, Wockhardt, Paras Healthcare, The Calcutta Medical Research Institute, Jehangir Hospital, and Ruby Hall to operate dialysis clinics. Additionally, they have expanded internationally via hospital partnerships, acquisitions, and PPPs, strengthening their presence and delivering quality care across multiple geographies.

Objectives

Capital expenditure by company for opening new dialysis clinics in India
Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by company
General corporate purposes

Strengths & Risks

Strengths (4)

Operational Excellence: Dialysis requires frequent clinic visits, making accessibility vital. From one clinic in 2010, they have scaled to 519 across India, Nepal, Philippines, Uzbekistan by September 2025, spanning 328 cities.

Risks (4)

Operational and Reputational Risks: They face operational, reputational, medical, and legal risks in dialysis services; non-compliance with quality standards may trigger litigation, liability, and materially impact their reputation, operations, and overall business performance.

Financials

Nephrocare Health Services Ltd IPO FAQs

When does the Nephrocare Health Services Ltd IPO open and close for subscription?

The Nephrocare Health Services Ltd IPO will open for subscription on Wednesday, December 10, 2025, and will close on Friday, December 12, 2025. 

The price band for the Nephrocare Health Services Ltd IPO is set at ₹438 to ₹460 per equity share

The minimum lot size for the Nephrocare Health Services Ltd IPO is 32 shares. Consequently, the minimum investment required for a retail investor is ₹14,016 at the lower price band (₹438 per share) and ₹14,720 at the upper price band (₹460 per share).

The total issue size of the Nephrocare Health Services Ltd IPO is up to 1,89,35,819 Equity Shares, consisting of both Fresh Issue and Offer for Sale. The aggregate monetary value is ₹ 871.05 Cr.

The book-running lead managers (BRLMs) for the Nephrocare Health Services Ltd IPO are ICICI Securities Limited, Ambit Private Limited, IIFL Capital Services Limited and Nomura Financial Advisory and Securities (India) Private Limited.

View More

*The financials mentioned above are sourced from DRHP/ RHP documents.